96 related articles for article (PubMed ID: 1378140)
1. The once-daily dose regimen of carvedilol: a meta-analysis approach.
Stienen U
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S128-33. PubMed ID: 1378140
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and metabolic effects of carvedilol: a meta-analysis approach.
Stienen U; Meyer-Sabellek W
Clin Investig; 1992; 70 Suppl 1():S65-72. PubMed ID: 1350487
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of carvedilol: a preliminary dose-response study.
Casadei B; Conway J; Coats AJ; Bird R
Clin Investig; 1992; 70 Suppl 1():S37-8. PubMed ID: 1350482
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
Weber MA; Bakris GL; Tarka EA; Iyengar M; Fleck R; Sica DA
J Clin Hypertens (Greenwich); 2006 Dec; 8(12):840-9. PubMed ID: 17170609
[TBL] [Abstract][Full Text] [Related]
5. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
Juttmann JR; de Vries Robles P; Venuti RP
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol in the treatment of mild to moderate hypertension: experience with ambulatory blood pressure monitoring.
Biston P; Van de Borne P; Mélot C; Smekens P; Marinus W; Degaute JP
Acta Cardiol; 1994; 49(2):145-55. PubMed ID: 8053282
[TBL] [Abstract][Full Text] [Related]
8. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
Bakris GL; Iyengar M; Lukas MA; Ordronneau P; Weber MA
J Clin Hypertens (Greenwich); 2010 Sep; 12(9):678-86. PubMed ID: 20883227
[TBL] [Abstract][Full Text] [Related]
9. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
[TBL] [Abstract][Full Text] [Related]
10. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
Young PH
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S82-5. PubMed ID: 1378155
[TBL] [Abstract][Full Text] [Related]
11. Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol.
Si D; Wang J; Xu Y; Chen X; Zhang M; Zhou H
J Cardiovasc Pharmacol; 2014 Oct; 64(4):306-9. PubMed ID: 25291495
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
Erdoğan O; Ertem B; Altun A
Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293
[TBL] [Abstract][Full Text] [Related]
13. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
McPhillips JJ; Schwemer GT; Scott DI; Zinny M; Patterson D
Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
[TBL] [Abstract][Full Text] [Related]
14. Response rate with respect to the blood pressure-lowering effect of the vasodilating and beta-blocking agent carvedilol.
Rittinghausen R
Drugs; 1988; 36 Suppl 6():92-101. PubMed ID: 2908307
[TBL] [Abstract][Full Text] [Related]
15. Controlled-release carvedilol in the treatment of essential hypertension.
Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of carvedilol in severe hypertension.
Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
[TBL] [Abstract][Full Text] [Related]
18. Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study.
Ayashi S; Assareh AR; Jalali MT; Olapour S; Yaghooti H
Indian J Pharmacol; 2016; 48(4):372-376. PubMed ID: 27756946
[TBL] [Abstract][Full Text] [Related]
19. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina.
Nahrendorf W; Rading A; Steinig G; van der Does R; Schlote A
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S114-6. PubMed ID: 1378136
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term carvedilol therapy on renal function in essential hypertension.
Tomita K; Marumo F
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S97-101. PubMed ID: 1378158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
